Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001214659-25-002306·Aprea Therapeutics, Inc.
Schedule 13G ownership disclosure
APREA THERAPEUTICS INC
Common stock, par value $0.001 per share · CUSIP: 03836J102
Event date: 2024-12-31
- Filing-level shares
- 276,603.00
- Percent of class
- 5.09%
- Sio Capital Management, LLC
Shares: 276,603.00 · Class: 5.09%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-002306
- Form type
- SCHEDULE 13G/A
- Filer
- Aprea Therapeutics, Inc.
- CIK
- CIK 1781983
- Filed
- Feb 10, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership